{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:02:16Z","timestamp":1793984536506,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010890","name":"Chinese Government Scholarship","doi-asserted-by":"publisher","award":["202208080011"],"award-info":[{"award-number":["202208080011"]}],"id":[{"id":"10.13039\/501100010890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Surgical resection is the only option to achieve long-term survival in cholangiocellular carcinoma (CCA). Due to limitations of health care systems and unforeseeable events, e.g., the COVID pandemic, the time from diagnosis to surgery (time-to-surgery (TTS)) has gained great interest in malignancies. Thus, we investigated whether TTS is associated with the oncological outcome in patients who underwent surgery for CCA. A cohort of 276 patients undergoing curative-intent surgery for intrahepatic and perihilar CCA excluding individuals with neoadjuvant therapy and perioperative mortality between 2010 and 2021 were eligible for analysis. Patients were grouped according to TTS (\u2264\u200930; 31\u201360; 61\u201390; &gt;\u200990\u00a0days) and compared by Kruskal\u2013Wallis-analysis. Survival was compared using Kaplan\u2013Meier analysis and characteristics associated with cancer-specific survival (CSS), recurrence-free survival (RFS) and overall survival (OS) using Cox regressions. The median CSS was 39\u00a0months (3-year-CSS\u2009=\u200952%, 5-year-CSS\u2009=\u200942%) and the median RFS 20\u00a0months (3-year-CSS\u2009=\u200938%, 5-year-CSS\u2009=\u200933%). In univariable Cox regressions, TTS was not associated with CSS (<jats:italic>p<\/jats:italic>\u2009=\u20090.971) or RFS (<jats:italic>p<\/jats:italic>\u2009=\u20090.855), respectively. A grouped analysis with respect to TTS (\u2264\u200930\u00a0days, n\u2009=\u2009106; 31\u201360\u00a0days, n\u2009=\u2009134; 61\u201390\u00a0days, n\u2009=\u200944;\u2009&gt;\u200990\u00a0days, n\u2009=\u200929) displayed a median CSS of 38, 33, 51 and 41\u00a0months and median RFS of 17, 22, 28 and 20\u00a0months (<jats:italic>p<\/jats:italic>\u2009=\u20090.971 log rank; <jats:italic>p<\/jats:italic>\u2009=\u20090.520 log rank). No statistical difference regarding oncological risk factors were observed between the groups. This study is the first comprehensive analysis of TTS in CCA patients. Within a representative European cohort, TTS was not associated with earlier tumor recurrence or reduced CCS.<\/jats:p>","DOI":"10.1038\/s41598-023-50842-6","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T16:03:33Z","timestamp":1705593813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Time to surgery is not an oncological risk factor in patients with cholangiocarcinoma undergoing curative-intent liver surgery"],"prefix":"10.1038","volume":"14","author":[{"given":"Anna","family":"Mantas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Constantin","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara Rosaline","family":"Heij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Bruners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven Arke","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom Florian","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf Peter","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bednarsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"issue":"4","key":"50842_CR1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1055\/s-2007-981195","volume":"132","author":"I Tischoff","year":"2007","unstructured":"Tischoff, I. & Tannapfel, A. Hepatocellular carcinoma and cholangiocarcinoma\u2013different prognosis, pathogenesis and therapy. Zentralbl Chir. 132(4), 300\u2013305. https:\/\/doi.org\/10.1055\/s-2007-981195 (2007).","journal-title":"Zentralbl Chir."},{"issue":"9","key":"50842_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: The next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17(9), 557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"50842_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrgastro.2011.20","volume":"8","author":"T Patel","year":"2011","unstructured":"Patel, T. Cholangiocarcinoma\u2013controversies and challenges. Nat. Rev. Gastroenterol. Hepatol. 8(4), 189\u2013200. https:\/\/doi.org\/10.1038\/nrgastro.2011.20 (2011).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"50842_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","volume":"71","author":"P Bertuccio","year":"2019","unstructured":"Bertuccio, P. et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J. Hepatol. 71(1), 104\u2013114. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.013 (2019).","journal-title":"J. Hepatol."},{"issue":"1","key":"50842_CR5","doi-asserted-by":"publisher","first-page":"100378","DOI":"10.1016\/j.esmoop.2021.100378","volume":"7","author":"A Lamarca","year":"2022","unstructured":"Lamarca, A., Edeline, J. & Goyal, L. How I treat biliary tract cancer. ESMO Open 7(1), 100378. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100378 (2022).","journal-title":"ESMO Open"},{"issue":"1","key":"50842_CR6","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1038\/s41598-021-82378-y","volume":"11","author":"J Bednarsch","year":"2021","unstructured":"Bednarsch, J. et al. Bacterial bile duct colonization in perihilar cholangiocarcinoma and its clinical significance. Sci. Rep. 11(1), 2926. https:\/\/doi.org\/10.1038\/s41598-021-82378-y (2021).","journal-title":"Sci. Rep."},{"issue":"5","key":"50842_CR7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/SLA.0000000000005103","volume":"274","author":"M Mueller","year":"2021","unstructured":"Mueller, M. et al. Perihilar cholangiocarcinoma\u2014novel benchmark values for surgical and oncological outcomes from 24 expert centers. Ann. Surg. 274(5), 780\u2013788. https:\/\/doi.org\/10.1097\/SLA.0000000000005103 (2021).","journal-title":"Ann. Surg."},{"key":"50842_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051392","author":"J Bednarsch","year":"2020","unstructured":"Bednarsch, J. et al. Leakage and stenosis of the hepaticojejunostomy following surgery for perihilar cholangiocarcinoma. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9051392 (2020).","journal-title":"J. Clin. Med."},{"key":"50842_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04407-1","author":"V Arndt","year":"2022","unstructured":"Arndt, V. et al. Cancer care in German centers of excellence during the first 2\u00a0years of the COVID-19 pandemic. J. Cancer Res. Clin. Oncol. https:\/\/doi.org\/10.1007\/s00432-022-04407-1 (2022).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"50842_CR10","doi-asserted-by":"publisher","first-page":"m4087","DOI":"10.1136\/bmj.m4087","volume":"371","author":"TP Hanna","year":"2020","unstructured":"Hanna, T. P. et al. Mortality due to cancer treatment delay: Systematic review and meta-analysis. Bmj 371, m4087. https:\/\/doi.org\/10.1136\/bmj.m4087 (2020).","journal-title":"Bmj"},{"key":"50842_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.09.011","author":"J Bednarsch","year":"2021","unstructured":"Bednarsch, J. et al. The prognostic role of in-hospital transfusion of fresh frozen plasma in patients with cholangiocarcinoma undergoing curative-intent liver surgery. Eur. J. Surg. Oncol. https:\/\/doi.org\/10.1016\/j.ejso.2021.09.011 (2021).","journal-title":"Eur. J. Surg. Oncol."},{"key":"50842_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2021.03.012","author":"J Bednarsch","year":"2021","unstructured":"Bednarsch, J. et al. The prognostic role of tumor-associated unilateral portal vein occlusion in perihilar cholangiocarcinoma. HPB https:\/\/doi.org\/10.1016\/j.hpb.2021.03.012 (2021).","journal-title":"HPB"},{"issue":"5","key":"50842_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose, J. N. et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): A randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 20(5), 663\u2013673. https:\/\/doi.org\/10.1016\/S1470-2045(18)30915-X (2019).","journal-title":"Lancet Oncol."},{"key":"50842_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184177","author":"M Ikemura","year":"2021","unstructured":"Ikemura, M. et al. Impact of the coronavirus disease-2019 pandemic on pancreaticobiliary disease detection and treatment. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm10184177 (2021).","journal-title":"J. Clin. Med."},{"issue":"5","key":"50842_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/hpb.12156","volume":"16","author":"AT Ruys","year":"2014","unstructured":"Ruys, A. T. et al. Delay in surgical treatment of patients with hilar cholangiocarcinoma: Does time impact outcomes?. HPB (Oxford). 16(5), 469\u2013474. https:\/\/doi.org\/10.1111\/hpb.12156 (2014).","journal-title":"HPB (Oxford)."},{"issue":"3","key":"50842_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/jso.25976","volume":"122","author":"AC Gamboa","year":"2020","unstructured":"Gamboa, A. C. et al. Optimal timing and treatment strategy for pancreatic cancer. J. Surg. Oncol. 122(3), 457\u2013468. https:\/\/doi.org\/10.1002\/jso.25976 (2020).","journal-title":"J. Surg. Oncol."},{"issue":"9","key":"50842_CR17","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1007\/s00268-021-06187-0","volume":"45","author":"K Okuno","year":"2021","unstructured":"Okuno, K. et al. Impact of preoperative time interval on survival in patients with gastric cancer. World J. Surg. 45(9), 2860\u20132867. https:\/\/doi.org\/10.1007\/s00268-021-06187-0 (2021).","journal-title":"World J. Surg."},{"issue":"1","key":"50842_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12029-020-00372-5","volume":"52","author":"EY Chen","year":"2021","unstructured":"Chen, E. Y. et al. Effect of time to surgery of colorectal liver metastases on survival. J. Gastrointest. Cancer 52(1), 169\u2013176. https:\/\/doi.org\/10.1007\/s12029-020-00372-5 (2021).","journal-title":"J. Gastrointest. Cancer"},{"issue":"5","key":"50842_CR19","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.3747\/co.27.6785","volume":"27","author":"S Bennett","year":"2020","unstructured":"Bennett, S. et al. Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic. Curr. Oncol. 27(5), e501\u2013e511. https:\/\/doi.org\/10.3747\/co.27.6785 (2020).","journal-title":"Curr. Oncol."},{"key":"50842_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132959","author":"J Bednarsch","year":"2021","unstructured":"Bednarsch, J. et al. Compelling long-term results for liver resection in early cholangiocarcinoma. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm10132959 (2021).","journal-title":"J. Clin. Med."},{"issue":"2","key":"50842_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/SLA.0000000000004322","volume":"275","author":"T Mizuno","year":"2022","unstructured":"Mizuno, T. et al. Combined vascular resection for locally advanced perihilar cholangiocarcinoma. Ann. Surg. 275(2), 382\u2013390. https:\/\/doi.org\/10.1097\/SLA.0000000000004322 (2022).","journal-title":"Ann. Surg."},{"issue":"4","key":"50842_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000449339","volume":"5","author":"T Yoh","year":"2016","unstructured":"Yoh, T. et al. Is Surgical resection justified for advanced intrahepatic cholangiocarcinoma?. Liver Cancer 5(4), 280\u2013289. https:\/\/doi.org\/10.1159\/000449339 (2016).","journal-title":"Liver Cancer"},{"issue":"8","key":"50842_CR23","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1245\/s10434-021-09811-4","volume":"28","author":"K Sahara","year":"2021","unstructured":"Sahara, K. et al. Defining the risk of early recurrence following curative-intent resection for distal cholangiocarcinoma. Ann. Surg. Oncol. 28(8), 4205\u20134213. https:\/\/doi.org\/10.1245\/s10434-021-09811-4 (2021).","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"50842_CR24","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.ejso.2019.04.019","volume":"45","author":"G Lurje","year":"2019","unstructured":"Lurje, G. et al. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma. Eur. J. Surg. Oncol. 45(8), 1468\u20131478. https:\/\/doi.org\/10.1016\/j.ejso.2019.04.019 (2019).","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"50842_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1245\/s10434-018-7075-4","volume":"26","author":"TB Tran","year":"2019","unstructured":"Tran, T. B. et al. Actual 5-year survivors after surgical resection of hilar cholangiocarcinoma. Ann. Surg. Oncol. 26(2), 611\u2013618. https:\/\/doi.org\/10.1245\/s10434-018-7075-4 (2019).","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"50842_CR26","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1245\/s10434-019-07306-x","volume":"26","author":"AG Lopez-Aguiar","year":"2019","unstructured":"Lopez-Aguiar, A. G. et al. Association of perioperative transfusion with recurrence and survival after resection of distal cholangiocarcinoma: A 10-institution study from the US extrahepatic biliary malignancy consortium. Ann. Surg. Oncol. 26(6), 1814\u20131823. https:\/\/doi.org\/10.1245\/s10434-019-07306-x (2019).","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"50842_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/hpb.12067","volume":"16","author":"E Tamoto","year":"2014","unstructured":"Tamoto, E. et al. Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma. HPB 16(1), 56\u201361. https:\/\/doi.org\/10.1111\/hpb.12067 (2014).","journal-title":"HPB"},{"issue":"10","key":"50842_CR28","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.hpb.2021.03.012","volume":"23","author":"J Bednarsch","year":"2021","unstructured":"Bednarsch, J. et al. The prognostic role of tumor-associated unilateral portal vein occlusion in perihilar cholangiocarcinoma. HPB 23(10), 1565\u20131577. https:\/\/doi.org\/10.1016\/j.hpb.2021.03.012 (2021).","journal-title":"HPB"},{"key":"50842_CR29","doi-asserted-by":"publisher","first-page":"628848","DOI":"10.3389\/fsurg.2021.628848","volume":"8","author":"JL Waterland","year":"2021","unstructured":"Waterland, J. L. et al. Efficacy of prehabilitation including exercise on postoperative outcomes following abdominal cancer surgery: A systematic review and meta-analysis. Front. Surg. 8, 628848. https:\/\/doi.org\/10.3389\/fsurg.2021.628848 (2021).","journal-title":"Front. Surg."},{"key":"50842_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-022-06761-0","author":"SR Jain","year":"2022","unstructured":"Jain, S. R. et al. The role and effect of multimodal prehabilitation before major abdominal surgery: A systemic review and meta-analysis. World J. Surg. https:\/\/doi.org\/10.1007\/s00268-022-06761-0 (2022).","journal-title":"World J. Surg."},{"key":"50842_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2016.01.060","author":"D Ribero","year":"2016","unstructured":"Ribero, D. et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J. Am. Coll. Surg. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2016.01.060 (2016).","journal-title":"J. Am. Coll. Surg."},{"issue":"10","key":"50842_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S2468-1253(18)30234-6","volume":"3","author":"RJS Coelen","year":"2018","unstructured":"Coelen, R. J. S. et al. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: A multicentre, randomised controlled trial. Lancet Gastroenterol. Hepatol. 3(10), 681\u2013690. https:\/\/doi.org\/10.1016\/S2468-1253(18)30234-6 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50842-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50842-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50842-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T20:01:31Z","timestamp":1705867291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50842-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50842"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-50842-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Anna Mantas, Dong Liu, Carlos Constantin Otto, Lara Rosaline Heij, Daniel Heise, Philipp Bruners, Sven Arke Lang, Tom Florian Ulmer, Ulf Peter Neumann and Jan Bednarsch declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1644"}}